Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

Hay, Charles R.M., Palmer, Ben, Chalmers, Elizabeth, Liesner, Ri, Maclean, Rhona, Rangarajan, Savita, Williams, Michael, Collins, Peter W., on behalf of United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) · 2011 · Blood

Abstract

The age-adjusted incidence of new factor VIII inhibitors was analyzed in all United Kingdom patients with severe hemophilia A between 1990 and 2009. Three hundred fifteen new inhibitors were reported to the National Hemophilia Database in 2528 patients with severe hemophilia who were followed up for a median (interquartile range) of 12 (4-19) years. One hundred sixty (51%) of these arose in patients ≥ 5 years of age after a median (interquartile range) of 6 (4-11) years' follow-up. The incidence of new inhibitors was 64.29 per 1000 treatment-years in patients < 5 years of age and 5.31 per 1000 treatment-years at age 10-49 years, rising significantly (P = .01) to 10.49 per 1000 treatment-years in patients more than 60 years of age. Factor VIII inhibitors arise in patients with hemophilia A throughout life with a bimodal risk, being greatest in early childhood and in old age. HIV was associated with significantly fewer new inhibitors. The inhibitor incidence rate ratio in HIV-seropositive patients was 0.32 times that observed in HIV-seronegative patients (P < .001). Further study is required to explore the natural history of later-onset factor VIII inhibitors and to investigate other potential risk factors for inhibitor development in previously treated patients.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2010-09-308668

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 17 references

Cited by

See all 174

Metadata

Authors
Hay, C. R. M., Palmer, B., Chalmers, E., Liesner, R., Maclean, R., Rangarajan, S., Williams, M., Collins, P. W., & on behalf of United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO)
Affiliations
  • Manchester Royal Infirmary (GB)
  • The United Kingdom National Haemophilia Database, Manchester, United Kingdom;
  • Department of Haematology, Glasgow Hospital for Sick Children, Yorkhill, Glasgow, United Kingdom;
  • Great Ormond Street Hospital (GB)
  • Royal Hallamshire Hospital (GB)
  • St Thomas' Hospital (GB)
  • Birmingham Children's Hospital (GB)
  • University Hospital of Wales (GB)
Venue
Blood
Published
2011-06-09
Volume
117
Issue
23
Pages
6367-6370
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2100236686
Cited by
174
References
17
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 8 · 2021: 11 · 2020: 15 · 2019: 5 · 2018: 19 · 2017: 17 · 2016: 13 · 2015: 17 · 2014: 16 · 2013: 15 · 2012: 19
FWCI
11.85
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords
factor VIII inhibitors, hemophilia A, inhibitor incidence, age-related risk, HIV infection, risk factors
MeSH terms
Adolescent, Adult, Age Factors, Child, Child, Preschool, Factor VIII, Female, United Kingdom, Hemophilia A, HIV Seropositivity, Humans, Male, Retrospective Studies, Risk Factors, Incidence, Databases, Factual, Blood Coagulation Factor Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. https://app.cochat.ai/papers/10.1182/blood-2010-09-308668
The paper
Hay, C. R. M., Palmer, B., Chalmers, E., Liesner, R., Maclean, R., Rangarajan, S., Williams, M., Collins, P. W., & on behalf of United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO). (2011). Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom. Blood. https://doi.org/10.1182/blood-2010-09-308668

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.